Webinar | Eliminate AI Hallucinations in R&D | 20 November; 12 PM ET: Register Now

Nanotransfer

Nanotransfer is a developer of gene therapies designed to create changes in the biotechnological market and in the treatment of genetic diseases
2021
02-Oct
02-10
Cordoba, Argentina
  • Drug Discovery and Development
  • Personalized Medicine Technologies

Innovation

Industry Problem

Gene therapies need delivery methods that can move genetic material into target cells without viral vectors.

R&D Focus

Non-viral gene delivery and nanoscale transfection systems.

Innovative Solution

Develops nanotechnology-based methods for transferring genetic payloads into cells.

Investment Funding

Last Funding Stage

Preseed

Total Funding Amount

$200K

Last Funding Amount

$200K

Startup Stage

Early Stage

Lead Investors

Grid Exponential

People

Founders

CEO

About

Nanotransfer is a developer of gene therapies designed to create changes in the biotechnological market and in the treatment of genetic diseases

Products

Product

Non-viral nanotransfer gene-delivery platform.

Demo Product or Complete Product?

Early development and research-collaboration stage.

Something missing or incorrect on this page? Help us enrich this information